Welcome to our dedicated page for Chimera Investment Corporation news (Ticker: $CIM), a resource for investors and traders seeking the latest updates and insights on Chimera Investment Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Chimera Investment Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Chimera Investment Corporation's position in the market.
Chimera Investment (NYSE: CIM) announced the closing of its public offering of $65 million in 9.000% senior notes due 2029. The notes are expected to trade on the NYSE under the symbol 'CIMN' starting May 28, 2024, and received a BBB investment grade rating from Egan-Jones. The offering aims to diversify Chimera's capital structure and support the acquisition of high-yielding assets. The transaction was managed by prominent financial firms including Morgan Stanley and RBC Capital Markets. Legal advisors included Hunton Andrews Kurth LLP and Venable LLP.
Chimera Investment (NYSE: CIM) announced a public offering of $65 million in 9.00% senior notes due 2029. Underwriters have a 30-day option to purchase up to an additional $9.75 million. The offering is expected to close on May 22, 2024, subject to customary conditions. The notes are to be listed on the NYSE under 'CIMN' and trading is expected to start within 30 days post-issuance. Proceeds will be used to acquire various mortgage assets and for general corporate purposes. Interest on the notes will be paid quarterly starting August 15, 2024, with maturity on May 15, 2029. The notes are senior unsecured obligations and can be redeemed starting May 15, 2026. Joint book-running managers include Morgan Stanley, RBC Capital Markets, UBS Securities, Wells Fargo Securities, Keefe, Bruyette & Woods, and Piper Sandler.
Chimera Investment (CIM) has announced a 1-for-3 reverse stock split, with the effective date set for May 21, 2024. The split will reduce the number of outstanding shares from 241.4 million to 80.5 million and the authorized shares from 500 million to 166.7 million. The company aims to align its market capitalization with similar companies and make its stock more appealing to a wider range of investors. The split will not affect shareholders' ownership percentage, with fractional shares being cashed out based on the closing price on May 21, 2024. Stockholders will receive information from Computershare Trust Company, N.A., the transfer agent, on the process to exchange pre-split certificates for new shares.
Chimera has declared second quarter 2024 dividends for its preferred stocks, including $0.50 per share for Series A, $0.7094 per share for Series B, $0.484375 per share for Series C, and $0.6989 per share for Series D. The dividends are payable on July 1, 2024.
Chimera Investment (NYSE:CIM) reported a GAAP net income of $0.45 per diluted common share and earnings available for distribution of $0.12 per diluted common share for the first quarter of 2024. The company's GAAP book value increased to $7.11 per common share, reflecting an economic return of 7%. Chimera acquired $50 million in new issue mortgage securitizations and settled on $78 million of residential transition loans in the period. The company is a real estate investment trust primarily investing in mortgage assets.
